Miniature Multicellular Biological Constructs for High-Throughput Drug Safety Testing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current in vitro drug safety testing methods, such as 2D cell monolayers and 3D bioprinting, fail to accurately mimic the in vivo environment, limiting the quality of preclinical and clinical safety assessments due to large tissue construct sizes and low throughput.

Innovation Solution

The method involves suspending cells in a hydrogel, depositing them into microwells using a microarray spotter, and incubating to grow miniature multicellular biological constructs that mimic in vivo environments, enabling high-throughput testing and imaging.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If 3D bioprinting is used to create tissue constructs, then the in vivo environment is more accurately mimicked, but the tissue construct size becomes large and throughput becomes low

Engineering Contradiction:
Improveaccuracy of in vivo environment mimicryVSAvoidthroughput of tissue construction and testing
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The invention divides the tissue construct into multiple microwells arranged in an array, with each microwell containing a miniature construct. This segmentation allows parallel processing of multiple constructs simultaneously, dramatically increasing throughput while maintaining the accuracy of in vivo environment mimicry in each individual microwell.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention creates multiple copies of miniature tissue constructs within a single microwell array. Each microwell contains a replicated miniature construct that accurately mimics the in vivo environment, allowing high-throughput testing through parallel analysis of multiple identical or varied constructs.

Inventive Principle:
Principle #26Copying

2Reliability

If 3D bioprinting is used to create tissue constructs, then the in vivo environment is more accurately mimicked, but the tissue construct becomes difficult to image

Engineering Contradiction:
Improveaccuracy of in vivo environment mimicryVSAvoiddifficulty of imaging
Core Design Contradiction:
ReliabilityVSDifficulty of detecting and measuring

Solution Approach 1:

By segmenting the tissue construct into miniature sizes within individual microwells, the invention makes each construct accessible for high-resolution imaging. The small scale of each miniature construct allows penetration of imaging beams (light, fluorescence, etc.) throughout the entire construct, enabling detailed visualization of cellular structures and drug distribution that would be impossible in large-scale constructs.

Inventive Principle:
Principle #1Segmentation

3Ease of manufacture

If 2D cell monolayers or 3D cell spheroids are used, then the testing process is simple, but the in vivo environment is not adequately mimicked

Engineering Contradiction:
Improvesimplicity of testing processVSAvoidaccuracy of in vivo environment mimicry
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The invention transitions from 2D monolayers and simple 3D spheroids to miniature 3D constructs within microwells that replicate the spatial architecture and cellular complexity of in vivo tissues. This dimensional advancement maintains ease of manufacture through standardized microwell fabrication while achieving superior physiological relevance through controlled 3D cell arrangement and extracellular matrix integration.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for accurate preclinical and clinical drug safety testing by creating small-scale, in vivo-like environments for high-content imaging and testing, significantly improving the efficiency and accuracy of drug safety assessments.

Implementation Method 1

suspending cells in a hydrogel to form a cell suspension

Methodology Applied
Scientific EffectHydrogel: Hydrogel

Implementation Method 2

depositing the cell-suspension into a microwell using a microarray spotter

Methodology Applied
Scientific EffectMicroarray spotting:

Implementation Method 3

gelling the cell-suspension

Methodology Applied
Scientific EffectGelation: Gel

Data Source

PatentUS10934538B23D-printed miniature biological constructs
Publication Date: 2021.03.02 CLEVELAND STATE UNIVERSITY
  • US10934538B2 patent drawing
  • US10934538B2 patent drawing
  • US10934538B2 patent drawing

AI summary

A method of creating a miniature multicellular biological construct and a method for studying cellular environments using the miniature multicellular biological construct is provided. The method for making the miniature multicellular biological construct includes suspending cells in a hydrogel, depositing the cell-suspension into a microwell, gelling the cell-suspension, and incubating the cell-suspension. The method for studying cellular environments includes imaging the miniature multicellular biological construct.